Then, the GSTACE2 SDMA midofication and GFPRBD binding with GSTACE2 or methylatedGSTACE2 were detected by western blot, respectively
PubMed DOI Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010)
Karges gratefully acknowledges the financial support provided by the Liebig fellowship from the Chemical Industry Fund of the German Chemical Industry Association, the Life Sciences Bridge Award from the Aventis Foundation, and the Paul Ehrlich & Ludwig Darmstaedter Early Career Award 2024 a prize awarded by the Paul Ehrlich Foundation, Germany
The binding appears to activate intracellular signaling proteins that potentially act as molecular toggles
This is a novel, investigational tri-agonist peptide that acts on the GIP, GLP-1, and glucagon receptors
Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules